Member Info for Balanced66

What does this tell us - these businesses are worth more than people think.

https://www.prnewswire.co.uk/news-releases/thermo-fisher-scientific-announces-results-of-offer-to-acquire-qiagen-lapse-of-offer-and-termination-of-acquisition-agreement-822626632.html

From yesterday -Eton Pharmaceutical's second quarter results and looking very positive as say in regular discussions with FDA:

"Alkindi® Sprinkle Update

"Alkindi Sprinkle’s NDA is under review by the FDA for use as a replacement therapy for pediatric adrenal insufficiency. Eton and its development partner have been engaged in regular communication with the FDA, and Eton expects the FDA to meet the existing September 29, 2020 Prescription Drug User Fee Act (PDUFA) date without any disruption from COVID-19. Based on the communications received during the application’s ongoing review, Eton remains confident that the Alkindi Sprinkle application is approvable and is working aggressively on launch preparation activities. Eton has purchased initial commercial inventory and expects to be in position to launch the product shortly after the PDUFA date, if approved."

Good risk return ratio here.

As soon as practicable after the 13th August is mentioned:

"Deutsche Bank Aktiengesellschaft and American Stock Transfer & Trust Company, the settlement agents for the offer, expect to provide Thermo Fisher with a final determination of the number of shares tendered on Thursday, August 13, 2020.As soon as practicable after the determination is made, Thermo Fisher will publicly announce the final results and publish those results in the German Federal Gazette."

https://www.prnewswire.co.uk/news-releases/thermo-fisher-scientific-provides-process-overview-for-the-announcement-of-final-offer-results-806463750.html

Big drop in pog.

You are pleased I find them negative that says it all Surfie.

I think you have made your point about our fellow investor it doesn't need repeating on a daily basis and you don't have to read posts that you don't like.

At least I get the impression that most investors here like his posts or don't mind them. I remember him being here before I joined this chat and before you. He has more right to his postings than you and me then. In a similar vein people could object to your constant negativity how would you feel then?

Surfie

You went away for a while when the share price looked like it was going to smash £4 quickly and now you're back when things have paused and back to your favourite pastime of mocking a fellow poster.

I've only ever seen negativity from you and don't believe a real investor would be negative all the time

I don't know why you bother posting on this board you have never posted anything of use to me.

There is a saying, if one has nothing good to say he should remain quiet.

It's been approved before clinical trials have been completed so only normal people to have concerns.

https://www.washingtonpost.com/world/russia-unveils-coronavirus-vaccine-claiming-victory-in-global-race-before-final-testing-is-complete/2020/08/11/792f8a54-d813-11ea-a788-2ce86ce81129_story.html

A lot of questions remain it seems and you won't get any transparency from the Russians.

Agree you can't read too much into the big investors selling/increasing their stakes. Think RG may have a better record in his investment performance than some of the other fund management groups who tend to follow each other in their behaviours hence the mediocre returns from those types of funds.

The rich investors may do it for tax reasons/top slicing etc. If I recall correctly think RG went below 3% in his SNG holding when he was around 15% before readout? You would expect some derisking before readout but the sale to below 3% suggests other reasons for sale at SNG so these sales not a reliable indicator but worth noting nevertheless.

Happy to hold and value will come out imo in the end. By my rough workings out even 1 of the territories such as US for Alkindi on peak sales (and not including Europe and ROW and not including Chronocort) will lead to a couple of hundred million market cap on 20x earnings. For a growth stock 20x earnings is too low imo so on 30x, 40x market cap will be much higher.

What it requires is patience. All our holdings can't be double up in a month's time ones and a safe home for your money is just as important as risking it for potentially bigger returns short term.

Once approvals for Alkindi in US and Chronocort in Europe have hopefully been granted then this will be derisked. The testosterone drug is an extra bonus. We also have Chronocort for P3 in US hopefully a partner for that.

Just my thoughts please feel free to comment etc.

Manchego

Since you've raised it and I didn't want to mention it originally. There are Muslim investors here as well who I think would not be happy that A4UK is being addressed as "Allah"!

Also Prophets of God have the letters PBUH (Peace be Upon Him) after their name. It is misrepresenting the Muslim faith to put the letters (PBUH) after the name Allah as A4UK does that is never said in Islam and is incorrect. Perhaps A4UK is a new Muslim and is therefore not aware of these issues?

Anyway, I like A4UK's posts but he/she should leave religion out of it and keep this neutral for the consideration of others of that faith.

Anyway hope I haven't opened up a can of worms but the opportunity arose to mention it.

"The tests are not CE marked – assessed before being placed on the market in the European Economic Area – and have not received an exemption to be placed on the market during the pandemic." Good to have a minister on your board then and third world countries are accused of corruption when this sort of thing happens over there and the accusation would be justified in those circumstances.

https://www.google.com/amp/s/amp.theguardian.com/world/2020/aug/08/up-to-750000-uk-randox-covid-test-kits-recalled-over-safety-concerns

Wrong link:

https://www.gov.uk/government/news/update-on-randox-test-kits--2

Not sure if this update yesterday is different from the mid July"pause" of Random tests?

NHS Test and Trace as well now.

https://www.google.com/amp/s/amp.theguardian.com/world/2020/jul/16/uk-government-orders-halt-randox-covid-19-tests-over-safety-issues

Is it based on GPM NAV or GPM share price when you subscribe?

Why does GPSS have a lower NAV to GPM? Is it this one that is used for the subscription?

Like I said it makes no sense to me for them to be doing trials in care homes, for trials to be successful and then no contract? There has to be a contract at the end of it imo if trials successful.

Surfie your time is coming remember £4 and you're out?

Sharehunter will be relieved!

Going by the Google chart today's close looks like an all time end of day price!

And the journey is just beginning.

Shorters at Voleon are relying on artificial intelligence. We have the real thing on these boards and investors.